MIRAGEN THERAPEUTICS INC - COM (MGEN)

CUSIP: 60463E103

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM
Total 13F shares
8,940,195
Share change
+3,115,332
Total reported value
$62,674,115
Price per share
$7.01
Number of holders
58
Value change
+$21,377,223
Number of buys
38
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 60463E103?
CUSIP 60463E103 identifies MGEN - MIRAGEN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MIRAGEN THERAPEUTICS INC - COM (MGEN) as of Q1 2018

As of 31 Mar 2018, MIRAGEN THERAPEUTICS INC - COM (MGEN) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,940,195 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., Artal Group S.A., 683 Capital Management, LLC, JPMORGAN CHASE & CO, NORTHERN TRUST CORP, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 58 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.